Radiation Treatment of Lymph Node Recurrence From Prostate Cancer : is 11C-choline PET/CT Predictive of Survival Outcomes?

Prostate Cancer Clinical Trial

Official title:

Radiation Treatment of Lymph Node Recurrence From Prostate Cancer : is 11C-choline PET/CT Predictive of Survival Outcomes?

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06170164
• Other study ID #: Colina-HTT-LN
• Status: Completed
• Start date: October 8, 2015
• Est. completion date: November 25, 2015

Study information

• Verified date: December 2023
• Source: IRCCS San Raffaele
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The role of PET/CT with Choline in the restaging of prostatic disease is now universally recognized, and its use has become routine in numerous centers in Italy and abroad. The indication for the test is provided exclusively by an increase in PSA. It was interesting to understand whether these prognostic factors have an influence on the probability of detecting disease by PET with Choline to identify patients who have a greater probability of benefiting from the use of this method with the possibility of identifying the disease in earlier stages.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 68
• Est. completion date: November 25, 2015
• Est. primary completion date: November 25, 2015
• Gender: Male
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patients operated with radical prostatectomy

• patients that present biochemical recurrence of the disease;

Exclusion Criteria:

• patients <18 years

Related Conditions & MeSH terms

• Prostate Cancer
• Prostatic Neoplasms
• Recurrence

Intervention

Diagnostic Test:
• Diagnostic accuracy
The aim of the study is to evaluate whether the pathological stage of the disease, Gleason score, age at diagnosis, serum PSA value and PET parameters (SUV, MTV) are predictive factors of choline PET examination.

Locations

Country	Name	City	State
Italy	Irccs San Raffaele	Milano	Italia

Sponsors (1)

Lead Sponsor	Collaborator
IRCCS San Raffaele

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	PET/CT with Choline in the restaging of prostatic disease.	retrospective analysis of 68 patients with biochemical recurrence of prostase disease that performed PET/CT with choline for the restaging of the disease.	1 year